The gene expression profile of cardia intestinal metaplasia is similar to that of Barrett's esophagus, not gastric intestinal metaplasia

Diseases of the Esophagus

Volumn 24, Issue 7, 2011, Pages 516-522

  Oh, D S ^a   Demeester, S R ^a   Tanaka, K ^b   Marjoram, P ^b   Kuramochi, H ^b   Vallbohmer, D ^a   Danenberg, K ^b   Chandrasoma, P T ^b   Demeester, T R ^a   Hagen, J A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Barrett's esophagus; Cardia intestinal metaplasia; Endoscopy; Gastric intestinal metaplasia; Gene expression; GERD

Indexed keywords

ANTIHISTAMINIC AGENT; MESSENGER RNA; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CARDIA INTESTINE METAPLASIA; ENDOSCOPIC BIOPSY; FEMALE; GASTRIC INTESTINE METAPLASIA; GENE EXPRESSION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LASER CAPTURE MICRODISSECTION; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BARRETT ESOPHAGUS; CARDIA; DUODENUM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; METAPLASIA; MIDDLE AGED; STOMACH;

EID: 80053045921     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2010.01176.x     Document Type: Article

References (31)

1. Odze R D. Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am J Gastroenterol 2005; 100: 1853-67.
2. Chandrasoma P. Pathological basis of gastroesophageal reflux disease. World J Surg 2003; 27: 986-93.
3. Goldblum J R, Vicari J J, Falk G W etal. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. [see comment]. Gastroenterology 1998; 114: 633-9.
4. Morales T G, Bhattacharyya A, Johnson C, Sampliner R E. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia? Am J Gastroenterol 1997; 92: 1818-22.
5. El-Serag H B, Sonnenberg A, Jamal M M, Kunkel D, Crooks L, Feddersen R M. Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol 1999; 94: 622-7.
6. DeMeester S R, Wickramasinghe K S, Lord R V N etal. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. [see comment]. Am J Gastroenterol 2002; 97: 2514-23.
7. Csendes A, Smok G, Quiroz J etal. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia. Am J Gastroenterol 2002; 97: 554-60.
8. Couvelard A, Cauvin J M, Goldfain D etal. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. [see comment]. Gut 2001; 49: 761-6.
9. Sarbia M, Donner A, Franke C, Gabbert H E. Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: the role of histology and immunohistochemistry. Hum Pathol 2004; 35: 371-6.
10. Ormsby A H, Goldblum J R, Rice T W etal. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol 1999; 30: 288-94.
11. El-Zimaity H M, Graham D Y. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am J Gastroenterol 2001; 96: 1378-82.
12. Balaji N S, DeMeester S R, Wickramasinghe K S, Hagen J A, Peters J H, DeMeester T R. Etiology of intestinal metaplasia at the gastroesophageal junction. Surg Endosc 2003; 17: 43-8.
13. Goldblum J R, Richter J E, Vaezi M, Falk G W, Rice T W, Peek R M. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol 2002; 97: 302-11.
14. Glickman J N, Shahsafaei A, Odze R D. Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach. Am J Surg Pathol 2003; 27: 1357-65.
15. Schilling D, Spiethoff A, Rosenbaum A etal. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients. Pathol Res Pract 2005; 200: 801-5.
16. Bonner R F, Emmert-Buck M, Cole K etal. Laser capture microdissection: molecular analysis of tissue. Science 1997; 278: 1481-3.
17. Vallbohmer D, DeMeester S R, Oh D S etal. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus. Am J Gastroenterol 2006; 101: 1458-66.
18. Ambroise C, McLachlan G J. Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci U S A 2002; 99: 6562-6.
19. Hayward J. The lower end of the esophagus. Thorax 1961; 16: 36-41.
20. Chandrasoma P T, Der R, Ma Y, Dalton P, Taira M. Histology of the gastroesophageal junction: an autopsy study. [see comment]. Am J Surg Pathol 2000; 24: 402-9.
21. Kilgore S P, Ormsby A H, Gramlich T L etal. The gastric cardia is not a metaplastic mucosa secondary to gastroesophageal reflux disease (GERD). Gastroenterology 1999; 116: A213.
22. Jain R, Aquino D, Harford W V, Lee E, Spechler S J. Frequency of intestinal metaplasia at different sites in the esophagus and stomach. Gastroenterology 1998; 114: A160.
23. Oberg S, Peters J H, DeMeester T R etal. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997; 226: 522-30. Discussion 30-32.
24. Spechler S J. Intestinal metaplasia at the gastroesophageal junction. Gastroenterology 2004; 126: 567-75.
25. Chang Y, Gong J, Liu B, Zhang J, Dai F. Gene expression profiling in Barrett's esophagus and cardia intestinal metaplasia: a comparative analysis using cDNA microarray. World J Gastroenterol 2004; 10: 3194-6.
26. Goldblum J R. The significance and etiology of intestinal metaplasia of the esophagogastric junction. Ann Diagn Pathol 2002; 6: 67-73.
27. Clark G, Ireland A P, Peters J H, Chandrasoma P, DeMeester T R, Bremner C G. Short-segment Barrett's esophagus: a prevalent complication of gastroesophageal reflux disease with malignant potential. J Gastrointest Surg 1997; 1: 113-22.
28. Morales C P, Spechler S J. Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers. Am J Gastroenterol 2003; 98: 759-62.
29. Sharma P, Weston A P, Morales T, Topalovski M, Mayo M S, Sampliner R E. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut 2000; 46: 9-13.
30. Hirota W K, Loughney T M, Lazas D J, Maydonovitch C L, Rholl V, Wong R K. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 277-85.
31. Pohl H, Welch H G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-6.